Insulet Corp.
PODD
Rang in Aktien
#2092
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aktienkurs
$141.47
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$9.81B
Veränderung (1 Tag)
0.26%
Veränderung (1 Jahr)
-56.72%
Land
US
Handel Insulet Corp. (PODD)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Insulet Corp. (PODD)
Anzahl der ausstehenden Aktien zum June 2026: 69.30M
Laut den neuesten Finanzberichten und dem Aktienkurs von Insulet Corp. beträgt die aktuelle Anzahl der ausstehenden Aktien 69.30M. Am Ende von December 2023 hatte das Unternehmen 69.75M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Insulet Corp. (PODD) von 2002 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 69.30M | -1.11% |
| 2024 | 70.08M | 0.47% |
| 2023 | 69.75M | 0.54% |
| 2022 | 69.38M | 2.48% |
| 2021 | 67.70M | 4.58% |
| 2020 | 64.74M | 6.83% |
| 2019 | 60.59M | 2.95% |
| 2018 | 58.86M | 1.48% |
| 2017 | 58.00M | 2.32% |
| 2016 | 56.69M | -0.17% |
| 2015 | 56.79M | 2.08% |
| 2014 | 55.63M | 3.00% |
| 2013 | 54.01M | 12.70% |
| 2012 | 47.92M | 2.64% |
| 2011 | 46.69M | 17.88% |
| 2010 | 39.61M | 33.24% |
| 2009 | 29.73M | 7.66% |
| 2008 | 27.61M | 65.45% |
| 2007 | 16.69M | 1,719.35% |
| 2006 | 917.28K | 200.78% |
| 2005 | 304.96K | 5.11% |
| 2004 | 290.14K | 6.62% |
| 2003 | 272.12K | -8.49% |
| 2002 | 297.38K | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 1.74B | 2,415.30% |
US
|
|
| 1.28B | 1,750.13% |
IE
|
|
| 383.50M | 453.41% |
US
|
|
| 1.48B | 2,032.24% |
US
|
|
| - | - |
DE
|
